Recent Headlines
ALT BioPharma to Auction Lab Equipment Online on Monday, November 16, 2009
Opening Bids Start as Low as $5 on Hundreds of New and Used Centrifuges, Water Baths, HPLC Components, Incubators, Consumables, and More From Agilent, Perkin Elmer, Beckman and Others. - November 14, 2009 - American Laboratory Trading Inc.
Functional Genetics Announces Discovery of Target That Regulates Alzheimer's Disease
Investigators at Functional Genetics, working with scientists at the Burnham Institute for Medical Research, Stanford University and Rockefeller University, have utilized its proprietary RHGP discovery technology to identify a novel gene (Rps23r1) in mice that reduces the accumulation of two toxic... - November 14, 2009 - Functional Genetics, Inc.
AnaSpec Improves Sensitivity of SensoLyte® pNPP Alkaline Phosphatase Assays
AnaSpec’s SensoLyte® pNPP Alkaline Phosphatase Assay kits now contain a specially formulated pNPP substrate. This new substrate offers the following advantages: Ready to use – no need to reconstitute pNPP powder Improved sensitivity – detects as low as 0.02 ng alkaline... - November 11, 2009 - AnaSpec, EGT Group
Heath Decisions CIO Maurice Hagar Wins Business Leader Media's Movers & Shakers Award
Business Leader Media’s sixth annual award honors up-and-coming business leaders in the Triangle community. - November 08, 2009 - Health Decisions
Eurogentec Announces Agreement to Acquire AnaSpec, Inc.
Eurogentec S.A. announces today a final agreement for the acquisition of AnaSpec Inc, a privately held proteomics company based in Fremont, California. - October 25, 2009 - AnaSpec, EGT Group
AnaSpec Introduces New Cys-Containing b-Amyloid Peptides
AnaSpec has added the following amyloid peptides to its selection: b-amyloid (1-40) S26C; b-amyloid (1-42) S26C dimer; b-amyloid (1-42) S26C and other Cys-containing b-amyloid peptides - October 21, 2009 - AnaSpec, EGT Group
Health Decisions Builds a Network of International CROs Trained in High-Efficiency Adaptive Research
Adaptive CRO invites like-minded research organizations from around the world to get certified in Agile Clinical Development - October 18, 2009 - Health Decisions
AnaSpec Introduces Beta- Secretase Enzyme & Assay
As one of the world’s largest providers of beta-amyloid peptides and Alzheimer’s related research products, AnaSpec has announced its latest offering – the human recombinant beta-secretase enzyme. b- secretase (BACE1) is a key protease involved in the production of beta-amyloid... - October 18, 2009 - AnaSpec, EGT Group
Sustainable Now Technologies, Inc. Files Energy Conversion Machine Patent
Sustainable Now Technologies today announced the filing of their first patent describing their Energy Conversion Machine (ECM) technologies. - October 16, 2009 - Sustainable Now Technologies
AnaSpec Introduces Expanded Selection of Anti-Tau Antibodies
AnaSpec has announced the release of 4 additional new phosphospecific anti-Tau antibodies. - October 15, 2009 - AnaSpec, EGT Group
Solving the Challenges of Adaptive Clinical Trials: Web Seminar Will Reveal Universal, Risk-Resistant Methods for Improving Study Efficiency
Health Decisions and the Center for Business Intelligence present the webinar "Solving the Challenges of Clinical Trials," which will be held Wednesday, October 28 from 11:00 am to noon EDT. Health Decisions is also holding a weekly drawing for free registration passes (a value of $295). To enter, visit http://www.HealthDec.com/page/webinar. - October 09, 2009 - Health Decisions
AnaSpec Introduces Rat-Specific SensoLyte® 520 Renin Assay Kit
AnaSpec is pleased to announce the release of a rat renin specific assay – the SensoLyte® 520 Rat Renin Assay Kit. - October 07, 2009 - AnaSpec, EGT Group
AnaSpec Introduces Z-Fish™ Anti-p53 Antibodies
AnaSpec has announced the release of a zebrafish specific p53 antibody, the Z-Fish™ Anti-p53. - October 04, 2009 - AnaSpec, EGT Group
ANAVEX Contracts FORENAP Pharma for Clinical Trials of ANAVEX 2-73 in Alzheimer’s Disease
Anavex Life Sciences Corp. has selected FORENAP Pharma EURL as the contract research organization (CRO). - October 02, 2009 - Anavex Life Sciences Corp.
AnaSpec Introduces New HiLyte Fluor™ 405 Fluorescent Probe
AnaSpec has introduced the newest member of the HiLyte FluorTM family - HiLyte Fluor™ 405 (Ex/Em=404/428 nm), a bright blue fluorescent probe. HiLyte FluorTM dyes are a series of superior fluorescent labeling dyes that span the full visible spectrum. They are optimized for maximum brightness... - October 01, 2009 - AnaSpec, EGT Group
AnaSpec’s Published References Pass 800
As compiled by Stanford University’s Highwire Press, the number of published papers that cite AnaSpec’s products has passed 800. Products cited include AnaSpec’s custom and catalog peptides, antibodies, assay kits, dyes, standard amino acids, unusual amino acids and synthesis... - September 30, 2009 - AnaSpec, EGT Group
New HD360˚ Module Gives Clinical Trial Monitors Greater Control While Reducing Costs
Health Decisions integrates Monitor View into its HD360˚ clinical trial management system. - September 27, 2009 - Health Decisions
RayBiotech to Award Biomarker Discovery Grants
RayBiotech, Inc., today announced today the establishment of its Biomarker Discovery Pilot Grant program, consisting of restricted grants of $10,000 to $20,000 worth of RayBiotech products and services to conduct their proposed biomarker research, which would potentially be sufficient to generate preliminary data for additional grant funding. - September 26, 2009 - RayBiotech, Inc
MedSource Hires New Associate Director of Clinical Operations
MedSource, a Contract Research Organization (CRO) providing Phase I-IV clinical trials support, announced today that Ms. Parisa Jabbarzadegan has joined its company as Associate Director of Clinical Operations. With more than 12 years of experience in the clinical research industry she brings a... - September 25, 2009 - MedSource
MedSource, a Contract Research Organization (CRO) Specializing in Complex Clinical Trials, Ranked No. 11 on List of Fastest Growing Companies in Houston
Companies making the Houston Business Journal’s list were ranked by percentage of revenue growth over the past two years. - September 23, 2009 - MedSource
Anavex Completes Scale-Up Manufacturing of ANAVEX 2-73 for Phase I Alzheimer’s Disease Clinical Trials
Anavex Life Sciences Corp. today announced the completion of scale-up manufacturing of ANAVEX 2-73, its lead compound for the treatment of Alzheimer’s disease. - September 23, 2009 - Anavex Life Sciences Corp.
AnaSpec Introduces Custom Services & Reagents for Hydrocarbon-Stapled Peptides
AnaSpec now offers custom synthesis of hydrocarbon-stapled peptides. - September 20, 2009 - AnaSpec, EGT Group
BIOCOM Biotech and AnaSpec Sign Distributor Agreement
AnaSpec and BIOCOM Biotech today announced a non-exclusive distributor agreement that will allow BIOCOM Biotech to distribute AnaSpec’s catalog and custom products throughout South Africa. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted, “AnaSpec is pleased... - September 19, 2009 - AnaSpec, EGT Group
MedSource Named to Inc. 500/5000 List of Fastest-Growing Companies in America for the Second Time
Houston-based company ranks No. 1232 on the 2009 Inc. 5000 with three-year sales growth of 258 percent - September 08, 2009 - MedSource
AnaSpec Introduces Calcein AM for Live Cell Staining
Calcein AM (Calcein acetoxymethyl ester), a non-fluorescent, cell permeable compound, converts to the strongly green fluorescent calcein when hydrolyzed by intracellular esterases in live cells.1-2 It is widely used for determining cell viability since the fluorescence intensity of calcein is... - August 27, 2009 - AnaSpec, EGT Group
AnaSpec Introduces New Click Chemistry Reagents
Click chemistry is a newer approach to the synthesis of drug-like molecules that can accelerate the drug discovery process. Sharpless, et al. defined what makes a click reaction as one that is wide in scope and easy to perform, uses only readily available reagents, and is insensitive to oxygen and... - August 23, 2009 - AnaSpec, EGT Group
Caffeine Cuts Male Mating Success
New study suggests that, when long-term effects are considered, two commonly ingested stimulants are not created equal. - August 19, 2009 - Genescient Corporation
Health Decisions Contributes Adaptive Research Best Practices to Wiley’s "Clinical Trials Handbook"
CEO Michael Rosenberg authors an in-depth review of progressive research in new interdisciplinary manual - August 15, 2009 - Health Decisions
MedSource Hires New Vice President of Clinical Operations
MedSource specializes in complex diseases and study designs and has experience in more than 400 trials in Phases I-IV. - August 14, 2009 - MedSource
AnaSpec Introduces New Z-Fish™ Antibodies for Cell Cycle Control Research
AnaSpec is pleased to announce the release of a series of zebrafish specific Z-Fish™ antibodies for use in cell cycle control research. - August 13, 2009 - AnaSpec, EGT Group
AnaSpec Introduces New SensoLyte® 520 Thiol Quantitation Kit
AnaSpec has announced the release of the SensoLyte® 520 Thiol Quantitation Kit (patent pending), an ultra-sensitive, robust and easy-to-use fluorescent assay for measurement of total thiol level. - August 09, 2009 - AnaSpec, EGT Group
AnaSpec Introduces Industry’s First Suite of MOG Reagents & Assay Kits
AnaSpec is pleased to be the first in the industry to provide a whole suite of reagents and assay kits for the advancement of MS research. This includes MOG proteins, peptides, antibodies and assay kits. - July 26, 2009 - AnaSpec, EGT Group
Cellexus Launches 50 Litre Single-Use, Disposable Bioreactor System
This introduction of the 50 litre format follows the successful launch of the CellMaker Regular 8 litre system in October 2008. - July 26, 2009 - Cellexus Ltd
AnaSpec Introduces New SensoLyte® β-Galactosidase Assay Kits
AnaSpec is pleased to announce the release of 3 new assay kits for measuring β-galactosidase activity - July 23, 2009 - AnaSpec, EGT Group
Cellexus Launches the CellMaker Regular™ - New, Improved Single-Use Bioreactor System
CellMaker Regular™ providing higher Optical Densities (ODs) and Yields of Soluble Protein compared with flask grown cell cultures. - July 22, 2009 - Cellexus Ltd
AnaSpec Introduces New Z-Fish™ Anti-Caspase Antibodies
AnaSpec is pleased to provide research tools to keep pace with the growing needs of researchers using zebrafish as an experimental model. - July 18, 2009 - AnaSpec, EGT Group
AnaSpec Introduces New Z-Fish™ MMP Antibodies
In response to the growing needs of the research community for zebrafish specific antibodies, peptides and other products, AnaSpec has launched the exciting new Z-Fish™ series of antibodies. Z-Fish™ antibodies are raised strictly from peptide antigens derived from zebrafish protein... - July 11, 2009 - AnaSpec, EGT Group
Sustainable Now Technologies Release Report on the History of Fuel
Sustainable Now Technologies Inc. (SNT), an alternative energies technology manufacturer, called a press conference this morning to announce the release of a new comprehensive report, titled, “The History of Fuel.” - July 11, 2009 - Sustainable Now Technologies
AnaSpec Introduces Wide Selection of Fluorescent Lipophilic Tracers
Carbocyanine dyes can be used in a wide variety of application for long-term tracing of cells, including cell transplantation, migration, adhesion and fusion studies. - June 28, 2009 - AnaSpec, EGT Group
Sustainable Now Technologies Appoint Chief Operations Officer
Algae Bio-Reactor Manufacturer, Sustainable Now Technologies, officially recognizes Nathan Morrison as Chief of Operations. - June 27, 2009 - Sustainable Now Technologies
AnaSpec Introduces New SensoLyte® LSD1 Assay Kit
AnaSpec has announced the release of a new long wavelength assay for Lysine-Specific Demethylase –1 (LSD1), the SensoLyte® LSD1 Assay Kit, Ex/Em=530/590 nm. LSD1 is a histone-modifying enzyme catalyzing lysine demethylation of histone H3. It plays an important role in regulation of gene... - June 25, 2009 - AnaSpec, EGT Group
Dentists Are Throwing Away the Cling Film and Switching to SteriTouch Keyboard Covers
Recognising the risk of cross contamination, Dentists have often used rolls of cling film to cover their keyboards...both awkward and time consuming. The cling film is now being swapped for permanent covers which not only allow the keyboard to be cleaned and decontaminated in-situ, but also prevent bacterial and fungal growth in between cleaning cycles. - June 25, 2009 - SteriTouch Ltd
Nanomi Joins Consortium to Address Chronic Kidney Disease
Nanomi, a leading provider of microsphere-based drug delivery technologies to the pharmaceutical industry, announced today that it joined a consortium for the development of a therapy to prevent chronic kidney disease. In an aging population, the worldwide incidence of chronic kidney disease,... - June 25, 2009 - Nanomi
AnaSpec Introduces Fluorescent GO™ Peptides
Fluorescent peptides, peptides with a reporter fluorescent dye, are valuable probes used in visualizing intracellular processes and molecular interactions at the level of single cells.1 The fluorescent dye can be attached to the amino (N) or carboxy (C)-terminus, or in the case of FRET... - June 23, 2009 - AnaSpec, EGT Group
Anavex Appoints Dr. Hervé De Kergrohen as CEO to Lead Company Through Clinical Trials and Future Growth
Anavex Life Sciences Corp., (“ANAVEX”) (OTCBB: AVXL) today announced the immediate appointment of Hervé de Kergrohen, MD, MBA, as its Chief Executive Officer (CEO) and director. Dr. de Kergrohen is an accomplished senior executive who has successfully founded and developed... - June 18, 2009 - Anavex Life Sciences Corp.
Sustainable Now Technologies Incorporates
Sustainable Now Technologies, an alternative energies technology manufacturer, announced today the news of the company’s official incorporation. - June 10, 2009 - Sustainable Now Technologies
Merrion Pharmaceuticals Announces Positive Phase IIB Study for Orazol Tablet Form of Zoledronate IV Infusion at ASCO Annual Meeting
Weekly tablet delivers major new benefits for patients, doctors and payors: avoiding the need for burdensome and costly infusions and related infection risks; weekly tablet dosing offers potential for better safety and side effect profile of a ‘gold standard’ oncology drug. - June 06, 2009 - Merrion Pharmaceuticals
AnaSpec Signs Distribution Agreement with Bioeksma UAB
AnaSpec, Inc. and Bioeksma UAB today announced a non-exclusive distributor agreement that will allow Bioeksma UAB to distribute AnaSpec’s catalog and custom products throughout Lithuania and Latvia. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted, “AnaSpec... - June 05, 2009 - AnaSpec, EGT Group
RayBiotech Now Offers Nearly 500 ELISA Kits
RayBiotech, the Protein Array Pioneer Company, has just increased its product line of different ELISA kits to 495, including ones detecting cytokines, chemokines, growth factors, angiogenic factors and adipokines in human, mouse, and rat samples. - June 03, 2009 - RayBiotech, Inc
AnaSpec Introduces Industry’s First FRET-Based Thrombin Assay Kit
AnaSpec has announced the launch of the industry’s first FRET-based thrombin assay – the SensoLyte 520 Thrombin Activity Assay Kit. Thrombin, a serine protease, plays a central role in hemostasis by converting soluble plasma fibrinogen into an insoluble fibrin clot and by promoting... - May 30, 2009 - AnaSpec, EGT Group